向乳化提供了治疗方法来逆转细胞死亡抵抗
Yumin Wang1, Jinxia Chen2, Yan Wang3
1Department of Respiratory and Critical Care Medicine, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, 100049, People's Republic of China.
Drug design, development and therapy
|December 26, 2025
概括
乳糖化是一种新陈代谢过程,有助于细胞在癌症等疾病中抵抗受调细胞死亡 (RCD). 针对这一过程为治疗耐药性疾病提供了新的治疗策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 乳酸化是一种乳酸衍生后翻译性修饰.
- 它调节了在包括癌症在内的各种疾病中对受调节的细胞死亡 (RCD) 的抵抗.
研究的目的:
- 审查乳化作为疾病,特别是癌症中RCD耐药性的中央调节者的作用.
- 解剖乳化抑制铁亡,杯亡和亡的分子机制.
- 评估病理生理学影响,并讨论针对乳化的治疗策略.
主要方法:
- 文献综述综合了当前对乳糖化的理解.
- 分析涉及乳酸转移酶和乳酸脱酶的分子通路.
- 评估病理生理学作用和治疗干预措施.
主要成果:
- 乳化动态修改蛋白质,抑制关键细胞死亡途径 (铁亡,亡,细胞亡).
- 这种代谢-表观遗传交叉关系在疾病微环境中赋予了对RCD的抵抗力.
- 乳酸化促进癌症的治疗耐药性和病理弹性.
结论:
- 乳糖化是跨病理性RCD抗性的关键代谢调节剂.
- 向乳糖调节剂或将乳酸调节与RCD诱导剂相结合,显示出治疗的前景.
- 扰乱乳化可能会克服癌症中治疗不耐药的条件.
更多相关视频
12:28Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
7.7K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.5K
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K